Pinto, Francesco
 Distribuzione geografica
Continente #
EU - Europa 17.475
NA - Nord America 4.386
AS - Asia 1.567
SA - Sud America 167
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 23.675
Nazione #
IT - Italia 12.151
US - Stati Uniti d'America 4.304
DE - Germania 1.828
SE - Svezia 771
NL - Olanda 626
CN - Cina 551
SG - Singapore 504
UA - Ucraina 460
FR - Francia 432
PL - Polonia 267
GB - Regno Unito 257
IE - Irlanda 180
IN - India 177
BR - Brasile 132
ID - Indonesia 116
RU - Federazione Russa 106
FI - Finlandia 94
CH - Svizzera 87
CA - Canada 60
BE - Belgio 58
TR - Turchia 50
JP - Giappone 49
ES - Italia 33
CI - Costa d'Avorio 21
HK - Hong Kong 20
IR - Iran 20
MA - Marocco 18
AT - Austria 17
RO - Romania 15
AL - Albania 13
AR - Argentina 13
CZ - Repubblica Ceca 13
MX - Messico 12
EU - Europa 11
AZ - Azerbaigian 9
TW - Taiwan 9
AU - Australia 8
BZ - Belize 8
CO - Colombia 8
GR - Grecia 8
HU - Ungheria 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
EC - Ecuador 6
LT - Lituania 6
VN - Vietnam 6
BG - Bulgaria 5
SM - San Marino 5
TH - Thailandia 5
DK - Danimarca 4
EG - Egitto 4
LK - Sri Lanka 4
MY - Malesia 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
IL - Israele 3
IQ - Iraq 3
IS - Islanda 3
KG - Kirghizistan 3
LU - Lussemburgo 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BO - Bolivia 2
CL - Cile 2
CV - Capo Verde 2
EE - Estonia 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
UG - Uganda 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
GE - Georgia 1
MC - Monaco 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
VE - Venezuela 1
Totale 23.675
Città #
Milan 1.268
Rome 1.086
Chandler 913
Naples 346
Ashburn 326
Singapore 302
Jacksonville 245
Florence 225
Turin 224
San Mateo 191
Warsaw 183
Bologna 180
Ann Arbor 176
Dublin 173
Palermo 150
Wilmington 141
Bari 132
Nanjing 125
Catania 115
Genoa 109
Jakarta 107
Nürnberg 107
Dearborn 103
Houston 101
Verona 99
Los Angeles 95
Woodbridge 94
Fairfield 77
Nanchang 75
Bremen 70
Munich 70
Brescia 62
Lawrence 62
Kraków 60
Boston 59
Padova 58
New York 54
Redwood City 53
Venice 53
Beijing 51
Moscow 51
Cattolica 50
Seattle 50
Brussels 46
Parma 46
Cagliari 43
Princeton 42
Taranto 42
Ottawa 41
The Dalles 41
Chicago 40
Bergamo 37
Marseille 37
Perugia 35
Pescara 35
Messina 34
Reggio Emilia 34
Salerno 34
Lancaster 33
Livorno 32
Mountain View 32
Frankfurt am Main 30
Redmond 30
Falls Church 29
Izmir 29
Kadoma 28
Paris 28
Trieste 28
Kunming 27
Modena 27
Cambridge 25
Helsinki 24
Lucca 24
Novara 24
San Jose 24
Tianjin 24
Monza 23
Rimini 22
Abidjan 21
Augusta 21
Hyderabad 21
University Park 20
Hangzhou 19
Hebei 19
Caserta 18
Enterprise 18
Shenyang 18
Jiaxing 17
Lecce 17
Boardman 16
Hong Kong 16
Macerata 16
Pisa 16
Rende 15
São Paulo 15
Udine 15
Amsterdam 14
Bolzano 14
Changsha 14
Lauterbourg 14
Totale 9.775
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 9.874
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.109
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 843
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 792
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 481
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 351
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 344
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 305
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 267
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 262
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 259
Pros-IT CNR: an Italian prostate cancer monitoring project 232
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 201
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 181
Le infezioni delle vie urinarie 180
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 179
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 179
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 175
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY 160
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 155
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 153
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 147
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 142
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 138
The occult urothelial cancer 138
Metabolic reprogramming by malat1 depletion in prostate cancer 132
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 130
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 129
Male infertility: non-surgical therapy 129
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 129
Human factors in surgery: from Three Mile Island to the operating room 127
[Overactive bladder syndrome: the social and economic perspective] 126
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 123
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 122
Imaging in prostate cancer diagnosis: present role and future perspectives 121
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 121
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 119
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 119
Bladder and prostate metastasis from small cell lung cancer: a rare entity 118
Advanced bladder cancer: New agents and new approaches. A review 117
Hot topics in urological health economics. A mini review 117
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 117
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 117
Brachytherapy in men with prostate cancer: update on indications and outcomes 117
Imaging in prostate cancer staging: present role e future perspectives 112
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 110
Size of Bladder Cancers: Correlation among Different Types of Measurement 109
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 109
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 108
Imaging of renal cell carcinoma: state of the art and recent advances 107
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 107
Advanced bladder cancer: New agents and new approaches. A review 105
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 101
Inhibition of prostate efferent neurotransmission by amikacin 100
Imaging in prostate cancer staging: present role and future perspectives 99
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 98
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 97
The occult urothelial cancer 97
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 94
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 94
Therapeutic strategies in penile cancer: state of the art 93
Circumcision: history, religion and law 91
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 91
Imaging of renal cell carcinoma: state of the art and recent advances 90
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 90
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 89
Local relapse of prostate cancer after primary definitive treatment: the management 89
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 88
Imaging in prostate cancer diagnosis: present role and future perspectives 85
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 84
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 79
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 77
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 76
Anti-anginal drugs: Systematic review and clinical implications 75
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 74
A circulating miRNA assay as a first-line test for prostate cancer screening 71
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 71
A circulating miRNA assay as a first-line test for prostate cancer screening 69
Imaging of renal cell carcinoma: state of the art and recent advances. 67
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 66
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 59
Shock-wave lithotripsy or ureterorenoscopy for renal stones? 56
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 55
Anti-Anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment 53
The cost of treatment and follow-up of bladder cancer in Italy 50
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 50
Sports and Genitourinary Traumas 46
[Continuing evolution of statistical tests in medical research] 45
[Sport, infertility and erectile dysfunction] 45
[Doping and urologic tumors] 44
[Prostatitis syndromes and sporting activities] 43
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 40
Familial and hereditary prostate cancer by definition in an Italian surgical series: Clinical features and outcome 36
Circumcision: history, religion and law 34
Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer 33
Bladder tumor markers: A review of the literature 32
Markers for Urological Malignancies 26
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 24
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 24
Imaging in bladder cancer: Present role and future perspectives 22
Totale 23.656
Categoria #
all - tutte 57.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020341 0 0 0 0 0 0 0 0 0 0 207 134
2020/20211.342 66 126 71 115 201 80 140 58 143 83 187 72
2021/20221.427 126 90 62 119 111 77 66 181 102 102 177 214
2022/20233.938 364 344 266 461 187 407 173 316 428 255 417 320
2023/20245.910 321 534 389 462 453 452 481 587 430 582 561 658
2024/20256.829 596 683 721 649 777 592 632 638 841 577 123 0
Totale 23.862